Quale sarebbe il prezzo per GeneOne Life Science, Inc. (011000)

Il prezzo per GeneOne Life Science, Inc. (011000) è $1.85

Qual è la capitalizzazione di mercato per GeneOne Life Science, Inc. (011000)

La capitalizzazione di mercato per GeneOne Life Science, Inc. (011000) è $32.07M

GeneOne Life Science, Inc. (011000) Prezzo e Capitalizzazione di Mercato

GeneOne Life Science, Inc., a biopharmaceutical firm headquartered in Seoul, South Korea, was founded in 1976. The company focuses on the innovation and manufacturing of gene-based biomedical products. Its developmental pipeline features several candidates: GLS-1027 is in Phase I for nephropathy and inflammatory conditions, and also in Phase II trials for COVID-19. Similarly, GLS-1200 is being tested in Phase II for both Rhinosinusitis and COVID-19. Other compounds under development include GLS-3000 and GLS-5310 for SARS-CoV-2, GLS-5100 targeting VZV-Shingles, and GLS-5140 for SFTS. The company is also advancing GLS-5300 in Phase II for MERS, GLS-5700 in Phase I for Zika, and GLS-6150 in Phase I for hepatitis C, alongside GLS-6100 which is in a pre-clinical stage for hepatitis C. Additionally, through its subsidiary VGXI, Inc., GeneOne Life Science offers contract manufacturing services for nucleic acid-based products, specifically DNA plasmids and mRNA, under cGMP standards. The company adopted its current name in April 2014, having previously been known as VGX International Inc.

Il prezzo per 011000	Attivo B	Capitalizzazione del mercato a B	Risultati
$305,181 $32.07M	NVDA	$5.301T	+16,529,324.11%
$266,780 $32.07M	AAPL	$4.634T	+14,449,452.62%
$238,519 $32.07M	GOOG	$4.143T	+12,918,743.99%
$206,647 $32.07M	MSFT	$3.589T	+11,192,456.53%
$164,480 $32.07M	AMZN	$2.857T	+8,908,576.04%

Il prezzo per 011000

Attivo B

Capitalizzazione del mercato a B

Risultati

$305,181 $32.07M